moves capability into developmental sequencing kit ahead of 2027 launch
- Company expects to demonstrate detection of all 20 amino acids by year-end 2026, reinforcing Proteus development confidence.
- Planned 2027 commercial launch targets bringing the Proteus-based developmental sequencing kit to market after validation milestones.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.